Search

University of California MOG Peptide Glioblastoma Patent Application

The Regents of the University of California published European patent application EP4054596A1 on April 15, 2026, covering the use of MOG peptide for priming glioblastoma treatment. The application names six inventors and includes ten IPC classifications spanning peptide sequences, cancer therapeutics, and cellular immunotherapies across 31 designated contracting states.

Acne Treatment Patent EP3458079A1, University of California, Apr 15 2026

The European Patent Office published patent application EP3458079A1 titled 'Compositions and Methods for Treating Acne' on April 15, 2026. The applicants are the Regents of the University of California and the University of Pittsburgh of the Commonwealth System of Higher Education. The listed inventors include MODLIN, Robert L., MILLER, Jeffery F., MARINELLI, Laura J., and HATFULL, Graham F., with IPC classifications covering viral vectors (A61K 35/76) and acne treatment applications (A61P 17/10).

California Court of Appeal Unpublished Opinions, Last 60 Days

California Courts of Appeal published 1,367 unpublished opinions over the last 60 days across multiple districts (1st through 6th). Cases include criminal matters (People v. M.S., People v. Ortega, People v. Williams), civil disputes (Darden v. The Bd. of Trustees of Leland Stanford Jr. University), family law (Marriage of Rodrigues and Craig), and other proceedings (Conservatorship of R.R., Doe v. Regents of the U. of Cal.). Unpublished opinions may not be cited or relied upon by other courts or parties per California Rules of Court, rule 8.1115.